Study links gum health to rare kidney diseases
NCT ID NCT07575347
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at gum disease in people with rare kidney disorders like Alport syndrome, Fabry disease, and tuberous sclerosis, as well as lupus. Researchers will compare 100 participants to those with chronic kidney disease and healthy controls. They aim to understand how common and severe gum disease is in these groups, using a dental exam and health questionnaire.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study succeeds, it could reveal how gum disease affects rare kidney disorders and lupus, pointing toward better dental care for these patients.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't test any new therapy. The results may not apply to all patients with these conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALPORT SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fundeni Clinical Institute
RECRUITINGBucharest, 022328, Romania
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can early enzyme therapy save kidneys in fabry disease?
- Aging kidneys under the microscope: could a simple test predict failure?
- Blood-Derived clot may regrow bone in gum disease
- Can continued lucerastat access help fabry patients?
- Could your gut bacteria hold the key to protecting your kidneys?
- Gum disease clues: could hippo proteins be the missing link?